Health Care & Life Sciences » Biotechnology | Array BioPharma Inc.

Array BioPharma Inc. | Key People and Executives

Ron Squarer
Chief Executive Officer & Director
Kyle A. Lefkoff
Independent Director
Shalini Sharp
Independent Director
Charles M. Baum
Independent Director
John A. Orwin
Independent Director
Gwen A. Fyfe
Independent Director
Gil J. van Lunsen
Independent Director
Carrie Smith Cox
Chairman
Ron Squarer
Chief Executive Officer & Director
Andrew R. Robbins
Chief Operating Officer
Jason Haddock
CFO & Principal Accounting Officer
Victor Sandor
Chief Medical Officer
Nicholas A. Saccomano
Chief Scientific Officer
Andrea N. Flynn
Senior Director-IR & Communications
Tricia Haugeto
Director-Corporate Communications & Investor
Kimberly Pope
Senior Vice President-Human Resources
Curtis G. Oltmans
Secretary, Executive VP & General Counsel
Kyle A. Lefkoff
Independent Director
Shalini Sharp
Independent Director
Charles M. Baum
Independent Director
John A. Orwin
Independent Director
Gwen A. Fyfe
Independent Director
Gil J. van Lunsen
Independent Director

About Array BioPharma

View Profile
Address
3200 Walnut Street
Boulder Colorado 80301
United States
Employees -
Website http://www.arraybiopharma.com
Updated 07/08/2019
Array BioPharma, Inc. engages in the research, development, and commercialization of targeted small molecule drugs for the treatment of cancer and other high-burden diseases. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony Piscopio, K.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.